or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Ovarian Cancer Awareness Month

Floor Speech

By:
Date:
Location: Washington, DC

Mr. BROWN of Ohio. Mr. President, we recognize September as Ovarian Cancer Awareness Month.

This year, the American Cancer Society estimates that 22,000 women will develop ovarian cancer and more than 15,550 women will lose their battle with this deadly cancer.

In the last 40 years, the National Cancer Institute, NCI, academic medical centers, and researchers across the country have made remarkable strides in improving treatments and therapies for various cancers.

Today, there are 12 million Americans who are cancer survivors.

Despite this progress, effective treatments for some cancers--including ovarian cancer--remain elusive.

This month, we support these women, their families, and the tireless efforts of health care providers and researchers across the country.

That is why I joined more than a dozen Senate colleagues as an original cosponsor of the National Ovarian Cancer Awareness Month Resolution.

If detected earlier, an ovarian cancer patient has a 94 percent chance of surviving longer than 5 years.

However, only 20 percent of ovarian cancer is detected in its early stage, and when diagnosed in the advanced stage there is only a 30 percent chance of survival.

This makes ovarian cancer the deadliest of all gynecologic cancers.

The National Ovarian Cancer Awareness Resolution designates September as Ovarian Cancer Awareness Month and encourages the efforts of cancer advocates to increase public awareness.

It also supports the NCI and medical researchers work to develop a reliable early detection test.

I have long been an advocate of cancer patients and research.

During the health reform debate, I successfully worked to pass the Clinical Trials Amendment.

Because of the amendment's inclusion in the Affordable Care Act, ACA, health insurance companies can no longer use participation in a clinical trial as a reason to deny health insurance coverage for routine health care.

This provision of the ACA is especially important for diseases like ovarian cancer that desperately need advancements in effective therapies.

As we recognize the importance of advancing ovarian cancer research and commend the struggle ovarian cancer patients and survivors encounter, we must ensure that researchers get the necessary funding and patients receive access to comprehensive care and coverage.

I will continue to support the goals of Ovarian Cancer Awareness Month--not just in September--throughout the year.


Source:
Back to top